✦ LIBER ✦

A network meta-analysis of randomized, controlled trials of ustekinumab and adalimumab for moderate-to-severe psoriasis

✍ Scribed by Odom, D.; Brogan, A.; Talbird, S.E.; Schenkel, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab therapy for moderate to sever

✍ Alan Menter; Stephen K. Tyring; Kenneth Gordon; Alexa B. Kimball; Craig L. Leona 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Systematic review and meta-analysis of u

✍ Meng, Y.; Dongmei, L.; Yanbin, P.; Jinju, F.; Meile, T.; Binzhu, L.; Xiao, H.; P 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

Efficacy of biologics in the treatment o

✍ K. Reich; A.D. Burden; J.N. Eaton; N.S. Hawkins 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Efficacy and safety of systemic treatmen

✍ Schmitt, J.; Rosumeck, S.; Thomaschewski, G.; Sporbeck, B.; Haufe, E.; Nast, A. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Cost-efficacy of adalimumab, etanercept,

✍ C. Ferrándiz; A. García; A.J. Blasco; P. Lázaro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Efficacy and tolerability of biologic an

✍ J. Schmitt; Z. Zhang; G. Wozel; M. Meurer; W. Kirch 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB